Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study

Documenti analoghi

• Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the BLESS study
  di: Simona Lattanzi, et al.
  Pubblicazione: (2025)
• Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy
  di: Jacob Pellinen, et al.
  Pubblicazione: (2026)
• Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug‐resistant focal epilepsy
  di: Silvano R. Gefferie, et al.
  Pubblicazione: (2026)
• Add‐on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study
  di: Yulia Novitskaya, et al.
  Pubblicazione: (2024)
• The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam
  di: Bernhard J. Steinhoff, et al.
  Pubblicazione: (2024)